Analysis of failures in patients with FIGO atage IIIc 1-IIIc 2 endometrial cancer

Anticancer Research

Volumn 32, Issue 1, 2012, Pages 201-205

  Gadducci, Angiolo ^a   Cosio, Stefania ^a   Fabrini, Maria Grazia ^a   Guerrieri, Maria Elena ^a   Greco, Carlo ^a   Genazzani, Andrea Riccardo ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Chemotherapy; Endometrial cancer; Lymph node metastases; Lymphadenectomy; Prognosis; Radiotherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; PACLITAXEL;

ADULT; AORTA DISSECTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVOR; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DRUG FATALITY; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; LUNG EMBOLISM; LYMPH NODE DISSECTION; PELVIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIECTOMY; PELVIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT FAILURE;

EID: 84855649401     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bakkum-Gamez JN, Gonzalez-Bosquet J, Laack NN, Mariani A and Dowdy SC: Current issues in the management of endometrial cancer. Mayo Clin Proc 83: 97-112, 2008.
2. Maggino T, Romagnolo C, Landoni F, Sartori E, Zola P and Gadducci A: An analysis of approaches to the management of endometrial cancer in North America: a CTF study. Gynecol Oncol 68: 274-279, 1998. (Pubitemid 28183499)
3. Kilgore LC, Partridge EE, Alvarez RD, Austin JM, Shingleton HM, Noojin F 3rd and Conner W: Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 56: 29-33, 1995.
4. Trimble EL, Kosary C and Park RC: Lymph node sampling and survival in endometrial cancer. Gynecol Oncol 77: 340-343, 1998. (Pubitemid 29022315)
5. Cragun JM, Havrilesky LJ, Calingaert B, Synan I, Secord AA, Soper JT, Clarke-Pearson DL and Berchuck A: Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 23: 3668-3675, 2005.
6. Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R and Sakuragi N: Lymph-vascular space invasion and number of positive paraaortic node groups predict survival in node-positive patients with endometrial cancer. Gynecol Oncol 96: 651-657, 2005. (Pubitemid 40255483)
7. Mariani A, Dowdy SC, Cliby WA, Haddock MG, Keeney GL, Lesnick TG and Podratz KC: Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. Gynecol Oncol 101: 200-208, 2006.
8. Chan JK and Kapp DS: Role of complete lymphadenectomy in endometrioid uterine cancer. Lancet Oncol 8: 831-841, 2007. (Pubitemid 47321602)
9. Fujimoto T, Nanjyo H, Nakamura A, Yokoyama Y, Takano T, Shoji T, Nakahara K, Yamada H, Mizunuma H, Yaegashi N, Sugiyama T, Kurachi H, Sato A and Tanaka T: Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer. Gynecol Oncol 107: 253-259, 2007.
10. Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, Angioli R, Tateo S, Mangili G, Katsaros D, Garozzo G, Campagnutta E, Donadello N, Greggi S, Melpignano M, Raspagliesi F, Ragni N, Cormio G, Grassi R, Franchi M, Giannarelli D, Fossati R, Torri V, Amoroso M, Crocè C and Mangioni C: Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100: 1707-1716, 2008.
11. Kitchener H, Swart AM, Qian Q, Amos C and Parmar MK, ASTEC Study Group: Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373: 125-136, 2009.
12. Gadducci A and Greco C: The evolving role of adjuvant therapy in endometrial cancer. Crit Rev Oncol Hematol 78: 79-91, 2011.
13. Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL, Heintz AP, Ngan HY and Pecorelli S: Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 95(Suppl 1): S105-143, 2006.
14. Creasman W: Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 105: 109, 2009.
15. Onda T, Yoshikawa H, Mizutani K, Mishima M, Yokota H, Nagano H, Ozaki Y, Murakami A, Ueda K and Taketani Y: Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy. Br J Cancer 75: 1836-1841, 1997. (Pubitemid 27230713)
16. Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, Fowler J, Thigpen JT and Benda JA: Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 24: 36-44, 2006. (Pubitemid 46630491)
17. Maggi R, Lissoni A, Spina F, Melpignano M, Zola P, Favalli G, Colombo A and Fossati R: Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer 95: 266-271, 2006. (Pubitemid 44187586)
18. Alvarez Secord A, Havrilesky LJ, Bae-Jump V, Chin J, Calingaert B, Bland A, Rutledge TL, Berchuck A, Clarke-Pearson DL and Gehrig PA: The role of multi-modality adjuvant chemotherapy and radiation in women with advanced-stage endometrial cancer. Gynecol Oncol 107: 285-291, 2007. (Pubitemid 47575727)
19. Susumu N, Sagae S, Udagawa Y, Niwa K, Kuramoto H, Satoh S and Kudo R; Japanese Gynecologic Oncology Group: Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecol Oncol 108: 226-233, 2008. (Pubitemid 350299451)
20. Hogberg T, Signorelli M, de Oliveira CF, Fossati R, Lissoni AA, Sorbe B, Andersson H, Grenman S, Lundgren C, Rosenberg P, Boman K, Tholander B, Scambia G, Reed N, Cormio G, Tognon G, Clarke J, Sawicki T, Zola P and Kristensen G: Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer-results from two randomised studies. Eur J Cancer 46: 2422-2431, 2010.
21. International Commission on Radiation Units and Measurements Report 38, Dose and Volume Specifications for Reporting Intracavitary Therapy in Gynecology. International Commission in Radiation Units and Measurements, Bethesda MD, pp. 1-23, 1985.
22. Hakmi A: Lymphadenectomy in endometrial cancer. Lancet 373: 1169, 2009.
23. Amant F, Neven P and Vergote I: Lymphadenectomy in endometrial cancer. Lancet 373: 1169-1170, 2009.
24. Creasman WT, Mutch DE and Herzog TJ: ASTEC lymphadenectomy and radiation therapy studies: Are conclusions valid? Gynecol Oncol 116: 293-294, 2010.
25. Corn BW, Lanciano RM, Greven KM, Schultz DJ, Reisinger SA, Stafford PM and Hanks GE: Endometrial cancer with para-aortic adenopathy: Patterns of failure and opportunities for cure. Int J Radiat Oncol Biol Phys 24: 223-227, 1992.
26. Rotman M, Aziz H and Boronow R: Insights in para-aortic radiation therapy for endometrial carcinoma. Int J Radiat Oncol Biol Phys 26: 711-712, 1993. (Pubitemid 23220176)
27. Aoki Y, Kase H, Watanabe M, Sato T, Kurata H and Tanaka K: Stage III endometrial cancer: analysis of prognostic factors and failure patterns after adjuvant chemotherapy. Gynecol Oncol 83: 1-5, 2001. (Pubitemid 32959871)
28. Fleming GF, Brunetto VL, Cella D, Look KY, Reid GC, Munkarah AR, Kline R, Burger RA, Goodman A and Burks RT: Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 22: 2159-2166, 2004. (Pubitemid 41095150)
29. Mangili G, De Marzi P, Beatrice S, Rabaiotti E, Viganò R, Frigerio L, Gentile C and Fazio F: Paclitaxel and concomitant radiotherapy in high-risk endometrial cancer patients: preliminary findings. BMC Cancer 6: 198, 2006.
30. Greven K, Winter K, Underhill K, Fontenesci J, Cooper J and Burke T: Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol Oncol 105: 155-159, 2006. (Pubitemid 44374683)